1-3 of 3
Madlaina Breuleux, PhD DAS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimal Residual Disease Status with Venetoclax Monotherapy Is Associated with Progression-Free Survival in Chronic Lymphocytic Leukemia

William G. Wierda, MD PhD, Andrew W. Roberts, MBBS, PhD, Paolo Ghia, MD PhD, Jennifer R. Brown, MD PhD, Stephan Stilgenbauer, Florence Cymbalista, MD, Nicole Lamanna, MD, John F. Seymour, MBBS, PhD, Sebastian Böttcher, MD, Madlaina Breuleux, PhD DAS, Brenda Chyla, Lang Zhou, PhD, Jacqueline Nielsen, PhD, Su Young Kim, MD PhD, Jalaja Potluri, MD, Johnathan C. Maher, PhD, Peter Hillmen, MB ChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 3134.
https://doi.org/10.1182/blood-2018-99-110183
Published: 2018
Journal Articles

Venetoclax Improves Quality of Life for Patients with Elapsed/Refractory Chronic Lymphocytic Leukemia

Tara Cochrane, BMBS, FRACP, FRCPA, Tatiana Chagorova, MD, Tadeusz Robak, MD PhD, Su-Peng Yeh, MD, Evgeny Nikitin, MD, Madlaina Breuleux, PhD DAS, Abdullah Masud, PhD, Kavita Sail, PhD, Viktor Komlosi, MD PhD, Mary Ann Anderson, FRACP, FRCPA, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4858.
https://doi.org/10.1182/blood-2018-99-117127
Published: 2018
Journal Articles

Efficacy and Safety of Ibrutinib (IBR) after Venetoclax (VEN) Treatment in IBR-Naïve Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Follow-up of Patients from the MURANO Study

Richard Greil, MD, Graeme Fraser, Brian Leber, MD, Reinhard Marks, Giulia Quaresmini, Jan Moritz Middeke, Gianpietro Semenzato, William Schary, Michelle Boyer, Madlaina Breuleux, PhD DAS, Noelle Crompton, Kathryn Humphrey, Paula Marlton
Journal: Blood
Blood (2018) 132 (Supplement 1): 5548.
https://doi.org/10.1182/blood-2018-99-118148
Published: 2018